Nimble niche Small life sciences consulting firm with a focused service mix around science, communications, and project management, presenting a potential opportunity to upsell broader end-to-end pharmaceutical operations and launch support to similar-sized clients seeking efficiency gains.

Expansion potential Recent partnerships and a network of seasoned experts position 3Sixty as a partner for mid-market biotech and medtech companies needing rapid, scalable support without full-time headcount; target firms planning faster product development timelines.

Sustainability angle Coaching and process-focused services can be framed around accelerating compliant, quality-driven product launches, aligning with emerging market expectations for efficient, reproducible development pipelines—a compelling angle for CDMOs and contract services.

Technology stack Utilizes modern web and security technologies (Cloudflare, WordPress, Bootstrap) indicating an approachable, cost-conscious profile; potential for cross-sell into digital transformation, regulatory information management, and secure collaboration tools for clients.

Financial cue Revenue range of 1M–10M suggests the opportunity to target growing startups and mid-market players who may seek advisory, process improvement, and launch execution services to scale efficiently without large firms’ price tags.